PODCAST-19: FiveThirtyEight on the Novel Coronavirus
Podcast autorstwa FiveThirtyEight, Anna Rothschild
46 Odcinki
-
Pandemics Don't Really End
Opublikowany: 14.07.2021 -
How The CDC's Blindspots Complicated The Fight Against COVID-19
Opublikowany: 30.06.2021 -
The Lab Leak Commotion
Opublikowany: 2.06.2021 -
Who Should Decide Who Gets To Make COVID-19 Vaccines?
Opublikowany: 22.05.2021 -
How To Make Sure Your Kid Isn't A Superspreader
Opublikowany: 7.05.2021 -
You Might Have Given The Coronavirus To Your Cat
Opublikowany: 28.04.2021 -
What A Donated Vaccine Can Do
Opublikowany: 22.04.2021 -
The Johnson & Johnson Pause Shows The System Is Working
Opublikowany: 13.04.2021 -
What The Heck Is Going On With AstraZeneca's Vaccine?
Opublikowany: 26.03.2021 -
How To Overcome Vaccine Hesitancy
Opublikowany: 22.03.2021 -
The COVID-19 Endemic
Opublikowany: 6.03.2021 -
How Variants Complicate Everything
Opublikowany: 19.02.2021 -
The Ethical Dilemmas Prompted By The Vaccine Rollout
Opublikowany: 5.02.2021 -
What Happens Once You Get An mRNA Vaccine
Opublikowany: 15.01.2021 -
Answering All (Or At Least Some) Of Your Vaccine Questions
Opublikowany: 7.01.2021 -
The Dr. Fauci Holiday Special
Opublikowany: 22.12.2020 -
Why Emily Oster Made Her Own COVID-19 Database
Opublikowany: 11.12.2020 -
How To Trust That A COVID-19 Vaccine Is Safe
Opublikowany: 21.11.2020 -
There's No Longterm Plan For Long COVID
Opublikowany: 13.11.2020 -
What To Make Of Pfizer's Big Vaccine Announcement
Opublikowany: 10.11.2020
FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We do it all with FiveThirtyEight's trademark blend of transparency and rigor.
